Market Tracker

07/01 6:45pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

136.73
Delayed Data
As of Jul 01
 -0.05 / -0.04%
Today’s Change
55.36
Today|||52-Week Range
141.51
+51.25%
Year-to-Date

Today’s Trading

Previous close136.78
Today’s open138.54
Day’s range135.81 - 138.71
Volume840,344
Average volume (3 months)1,290,366
Market cap$21.9B
Dividend yield--
Data as of 3:59pm ET, 07/01/2015

Growth & Valuation

Earnings growth (last year)+28.13%
Earnings growth (this year)-133.25%
Earnings growth (next 5 years)+40.30%
Revenue growth (last year)+36.76%
P/E ratioNM
Price/Sales17.64
Price/Book13.35

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.21+0.44%
INCYIncyte Corp+0.24+0.23%
PRGOPerrigo Company PLC+0.23+0.12%
ENDPEndo International P...+1.24+1.56%
Data as of 4:04pm ET, 07/01/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$750.0M
Annual profit (last year)-$134.0M
Net profit margin-17.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts